These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 35003035)

  • 1. Dioctanoyl Ultrashort Tetrabasic β-Peptides Sensitize Multidrug-Resistant Gram-Negative Bacteria to Novobiocin and Rifampicin.
    Ramirez D; Berry L; Domalaon R; Li Y; Arthur G; Kumar A; Schweizer F
    Front Microbiol; 2021; 12():803309. PubMed ID: 35003035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dilipid Ultrashort Tetrabasic Peptidomimetics Potentiate Novobiocin and Rifampicin Against Multidrug-Resistant Gram-Negative Bacteria.
    Ramirez D; Berry L; Domalaon R; Brizuela M; Schweizer F
    ACS Infect Dis; 2020 Jun; 6(6):1413-1426. PubMed ID: 32357292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Lysine
    Schweizer L; Ramirez D; Schweizer F
    Antibiotics (Basel); 2022 Mar; 11(3):. PubMed ID: 35326798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repurposing Azithromycin and Rifampicin Against Gram-Negative Pathogens by Combination With Peptidomimetics.
    Baker KR; Jana B; Hansen AM; Nielsen HM; Franzyk H; Guardabassi L
    Front Cell Infect Microbiol; 2019; 9():236. PubMed ID: 31334131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotic Potentiation in Multidrug-Resistant Gram-Negative Pathogenic Bacteria by a Synthetic Peptidomimetic.
    Mood EH; Goltermann L; Brolin C; Cavaco LM; Nejad AJ; Yavari N; Frederiksen N; Franzyk H; Nielsen PE
    ACS Infect Dis; 2021 Aug; 7(8):2152-2163. PubMed ID: 34227804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global Assessment of the Activity of Tigecycline against Multidrug-Resistant Gram-Negative Pathogens between 2004 and 2014 as Part of the Tigecycline Evaluation and Surveillance Trial.
    Giammanco A; Calà C; Fasciana T; Dowzicky MJ
    mSphere; 2017; 2(1):. PubMed ID: 28124025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repurposing azithromycin and rifampicin against Gram-negative pathogens by combination with peptide potentiators.
    Baker KR; Jana B; Hansen AM; Vissing KJ; Nielsen HM; Franzyk H; Guardabassi L
    Int J Antimicrob Agents; 2019 Jun; 53(6):868-872. PubMed ID: 30447380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
    Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
    Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Azaindole Based Potentiator of Antibiotics against Gram-Negative Bacteria.
    Sharma S; Rao R; Reeve SM; Phelps GA; Bharatham N; Katagihallimath N; Ramachandran V; Raveendran S; Sarma M; Nath A; Thomas T; Manickam D; Nagaraj S; Balasubramanian V; Lee RE; Hameed P S; Datta S
    ACS Infect Dis; 2021 Nov; 7(11):3009-3024. PubMed ID: 34699190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of distribution and drug resistance of pathogens from the wounds of 1 310 thermal burn patients].
    Zhang C; Gong YL; Luo XQ; Liu MX; Peng YZ
    Zhonghua Shao Shang Za Zhi; 2018 Nov; 34(11):802-808. PubMed ID: 30481922
    [No Abstract]   [Full Text] [Related]  

  • 11. Detection of diverse carbapenem and multidrug resistance genes and high-risk strain types among carbapenem non-susceptible clinical isolates of target gram-negative bacteria in Kenya.
    Musila L; Kyany'a C; Maybank R; Stam J; Oundo V; Sang W
    PLoS One; 2021; 16(2):e0246937. PubMed ID: 33617559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of tobramycin benzyl ether as an antibiotic adjuvant capable of sensitizing multidrug-resistant Gram-negative bacteria to rifampicin.
    Ramirez DM; Dhiman S; Mukherjee A; Wimalasekara R; Schweizer F
    RSC Med Chem; 2024 Mar; 15(3):1055-1065. PubMed ID: 38516601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysine-Based Small Molecule Sensitizes Rifampicin and Tetracycline against Multidrug-Resistant
    Konai MM; Haldar J
    ACS Infect Dis; 2020 Jan; 6(1):91-99. PubMed ID: 31646866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The tigecycline evaluation and surveillance trial; assessment of the activity of tigecycline and other selected antibiotics against gram-positive and gram-negative pathogens from France collected between 2004 and 2016.
    Decousser JW; Woerther PL; Soussy CJ; Fines-Guyon M; Dowzicky MJ
    Antimicrob Resist Infect Control; 2018; 7():68. PubMed ID: 29876099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repurposed Antimicrobial Combination Therapy: Tobramycin-Ciprofloxacin Hybrid Augments Activity of the Anticancer Drug Mitomycin C Against Multidrug-Resistant Gram-Negative Bacteria.
    Domalaon R; Ammeter D; Brizuela M; Gorityala BK; Zhanel GG; Schweizer F
    Front Microbiol; 2019; 10():1556. PubMed ID: 31354660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-Activity Studies with Bis-Amidines That Potentiate Gram-Positive Specific Antibiotics against Gram-Negative Pathogens.
    Wesseling CMJ; Slingerland CJ; Veraar S; Lok S; Martin NI
    ACS Infect Dis; 2021 Dec; 7(12):3314-3335. PubMed ID: 34766746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. When Combined with Colistin, an Otherwise Ineffective Rifampicin-Linezolid Combination Becomes Active in
    Armengol E; Asunción T; Viñas M; Sierra JM
    Microorganisms; 2020 Jan; 8(1):. PubMed ID: 31936387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli.
    Zhanel GG; Golden AR; Zelenitsky S; Wiebe K; Lawrence CK; Adam HJ; Idowu T; Domalaon R; Schweizer F; Zhanel MA; Lagacé-Wiens PRS; Walkty AJ; Noreddin A; Lynch Iii JP; Karlowsky JA
    Drugs; 2019 Feb; 79(3):271-289. PubMed ID: 30712199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dilipid ultrashort cationic lipopeptides as adjuvants for chloramphenicol and other conventional antibiotics against Gram-negative bacteria.
    Domalaon R; Brizuela M; Eisner B; Findlay B; Zhanel GG; Schweizer F
    Amino Acids; 2019 Mar; 51(3):383-393. PubMed ID: 30392097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amino-Acid-Conjugated Polymer-Rifampicin Combination: Effective at Tackling Drug-Resistant Gram-Negative Clinical Isolates.
    Barman S; Mukherjee S; Ghosh S; Haldar J
    ACS Appl Bio Mater; 2019 Dec; 2(12):5404-5414. PubMed ID: 35021539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.